{"slideshow_credits": null, "snippet": "A diverse biotechnology company hopes its genetically engineered mosquitoes can help stop the spread of a devastating virus. But that\u2019s just a start.", "abstract": "Randal J Kirk, owner of Intrexon biotech firm, controls what could be effective weapon against mosquitoes carrying Zika virus; has lobbied government to test company's genetically engineered mosquitoes, which have capacity to mate with wild ones and produce offspring that die before adulthood;  successful outcome could end spread of mosquito-born viruses, progress future of synthetic biology and boost Intrexon\u2019s bottom line.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2016/03/06/business/a-biotech-evangelist-seeks-a-zika-dividend.html", "lead_paragraph": "A diverse biotechnology company hopes its genetically engineered mosquitoes can help stop the spread of a devastating virus. But that\u2019s just a start.", "headline": {"main": "A Biotech Evangelist Seeks a Zika Dividend", "print_headline": "Seeking a Zika Dividend"}, "_id": "56dabd8638f0d83eee097acb", "word_count": "2707", "multimedia": [{"height": 126, "url": "images/2016/03/06/business/06INTREXON2/06INTREXON2-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/03/06/business/06INTREXON2/06INTREXON2-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2016/03/06/business/06INTREXON2/06INTREXON2-articleLarge.jpg", "legacy": {"xlarge": "images/2016/03/06/business/06INTREXON2/06INTREXON2-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/03/06/business/06INTREXON2/06INTREXON2-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2016/03/06/business/06INTREXON2/06INTREXON2-thumbStandard-v2.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-03-06T00:00:00Z", "source": "The New York Times", "news_desk": "SundayBusiness", "keywords": [{"name": "organizations", "value": "Intrexon Corporation", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Biotechnology and Bioengineering", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Mosquitoes", "is_major": "Y", "rank": "3"}, {"name": "persons", "value": "Kirk, Randal J (1953- )", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Zika Virus", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Genetic Engineering", "is_major": "N", "rank": "6"}, {"name": "subject", "value": "DNA (Deoxyribonucleic Acid)", "is_major": "N", "rank": "7"}, {"name": "subject", "value": "Synthetic Biology", "is_major": "N", "rank": "8"}], "blog": [], "subsection_name": null, "type_of_material": "News"}